Skip Nav Destination
Adult Burkitt leukemia and lymphoma
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
Issue Archive
Table of Contents
INSIDE BLOOD
REVIEW ARTICLES
Adult Burkitt leukemia and lymphoma
Clinical Trials & Observations
ERRATA
CHEMOKINES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial
Clinical Trials & Observations
Mathilde Hunault,Jean-Luc Harousseau,Martine Delain,Malgorzata Truchan-Graczyk,Jean-Yves Cahn,Francis Witz,Thierry Lamy,Bernard Pignon,Jean-Pierre Jouet,Reda Garidi,Denis Caillot,Christian Berthou,Denis Guyotat,Alain Sadoun,Jean-Jacques Sotto,Bruno Lioure,Philippe Casassus,Philippe Solal-Celigny,Laure Stalnikiewicz,Bruno Audhuy,Odile Blanchet,Laurence Baranger,Marie-Christine Béné,Norbert Ifrah,for the GOELAMS (Groupe Ouest-Est des Leucémies Aiguës et Maladies du Sang) Group
FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia
Clinical Trials & Observations
Animesh Pardanani,Stephanie R. Brockman,Sarah F. Paternoster,Heather C. Flynn,Rhett P. Ketterling,Terra L. Lasho,Ching-Liang Ho,Chin-Yang Li,Gordon W. Dewald,Ayalew Tefferi
Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study
Clinical Trials & Observations
Jeppe Frederiksen,Klaus Juul,Peer Grande,Gorm B. Jensen,Torben V. Schroeder,Anne Tybjærg-Hansen,Børge G. Nordestgaard
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial
Clinical Trials & Observations
Antonio Palumbo,Sara Bringhen,Maria Teresa Petrucci,Pellegrino Musto,Fausto Rossini,Martina Nunzi,Vito Michele Lauta,Cesare Bergonzi,Anna Barbui,Tommaso Caravita,Antonio Capaldi,Patrizia Pregno,Tommasina Guglielmelli,Mariella Grasso,Vincenzo Callea,Alessandra Bertola,Federica Cavallo,Patrizia Falco,Cecilia Rus,Massimo Massaia,Franco Mandelli,Angelo Michele Carella,Enrico Pogliani,Anna Marina Liberati,Franco Dammacco,Giovannino Ciccone,Mario Boccadoro
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia
Clinical Trials & Observations
William Tse,Soheil Meshinchi,Todd A. Alonzo,Derek L. Stirewalt,Robert B. Gerbing,William G. Woods,Frederick R. Appelbaum,Jerald P. Radich
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
Clinical Trials & Observations
Roswitha Forstpointner,Martin Dreyling,Roland Repp,Sandra Hermann,Annette Hänel,Bernd Metzner,Christiane Pott,Frank Hartmann,Frank Rothmann,Robert Rohrberg,Hans-Peter Böck,Hannes Wandt,Michael Unterhalt,Wolfgang Hiddemann
Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia
Clinical Trials & Observations
Wolfgang Kern,Daniela Voskova,Claudia Schoch,Wolfgang Hiddemann,Susanne Schnittger,Torsten Haferlach
HEMATOPOIESIS
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Reduced pigmentation (rp), a mouse model of Hermansky-Pudlak syndrome, encodes a novel component of the BLOC-1 complex
Babette Gwynn,Jose A. Martina,Juan S. Bonifacino,Elena V. Sviderskaya,M. Lynn Lamoreux,Dorothy C. Bennett,Kengo Moriyama,Marjan Huizing,Amanda Helip-Wooley,William A. Gahl,Lisa S. Webb,Amy J. Lambert,Luanne L. Peters
IMMUNOBIOLOGY
NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs
Christophe Borg,Abdelali Jalil,Diego Laderach,Kouji Maruyama,Hiro Wakasugi,Sabine Charrier,Bernhard Ryffel,Alessandra Cambi,Carl Figdor,William Vainchenker,Anne Galy,Anne Caignard,Laurence Zitvogel
Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase
Yoshimitsu Taguchi,Tadakazu Kondo,Mitsumasa Watanabe,Michihiko Miyaji,Hisanori Umehara,Yasunori Kozutsumi,Toshiro Okazaki
NEOPLASIA
Atypical marginal zone hyperplasia of mucosa-associated lymphoid tissue: a reactive condition of childhood showing immunoglobulin lambda light-chain restriction
Ayoma D. Attygalle,Hongxiang Liu,Sima Shirali,Timothy C. Diss,Christoph Loddenkemper,Harald Stein,Ahmet Dogan,Ming-Qing Du,Peter G. Isaacson
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma
Brief Report
Nicolaus Kröger,Avichai Shimoni,Maria Zagrivnaja,Francis Ayuk,Michael Lioznov,Heike Schieder,Helmut Renges,Boris Fehse,Tatjana Zabelina,Arnon Nagler,Axel R. Zander
RED CELLS
TRANSPLANTATION
Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation
Chang-Ki Min,Yoshinobu Maeda,Kathleen Lowler,Chen Liu,Shawn Clouthier,David Lofthus,Elizabeth Weisiger,James L. M. Ferrara,Pavan Reddy
CORRESPONDENCE
Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells
Boris Fehse,Francis A. Ayuk,Nicolaus Kröger,Lubin Fang,Klaus Kühlcke,Marion Heinzelmann,Tatjana Zabelina,Axel A. Fauser,Axel R. Zander
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals